Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 5

1.

RNAi screening of the kinome identifies modulators of cisplatin response in ovarian cancer cells.

Arora S, Bisanz KM, Peralta LA, Basu GD, Choudhary A, Tibes R, Azorsa DO.

Gynecol Oncol. 2010 Sep;118(3):220-7.

PMID:
20722101
[PubMed - indexed for MEDLINE]
2.

A high-content RNAi-screening assay to identify modulators of cholesterol accumulation in Niemann-Pick type C cells.

Arora S, Beaudry C, Bisanz KM, Sima C, Kiefer JA, Azorsa DO.

Assay Drug Dev Technol. 2010 Jun;8(3):295-320. doi: 10.1089/adt.2009.0240.

PMID:
20469965
[PubMed - indexed for MEDLINE]
3.

Chemogenomic analysis identifies Macbecin II as a compound specific for SMAD4-negative colon cancer cells.

Kaiser C, Meurice N, Gonzales IM, Arora S, Beaudry C, Bisanz KM, Robeson AC, Petit J, Azorsa DO.

Chem Biol Drug Des. 2010 Apr;75(4):360-8. doi: 10.1111/j.1747-0285.2010.00949.x.

PMID:
20331650
[PubMed - indexed for MEDLINE]
4.

High-content siRNA screening of the kinome identifies kinases involved in Alzheimer's disease-related tau hyperphosphorylation.

Azorsa DO, Robeson RH, Frost D, Meec hoovet B, Brautigam GR, Dickey C, Beaudry C, Basu GD, Holz DR, Hernandez JA, Bisanz KM, Gwinn L, Grover A, Rogers J, Reiman EM, Hutton M, Stephan DA, Mousses S, Dunckley T.

BMC Genomics. 2010 Jan 12;11:25. doi: 10.1186/1471-2164-11-25.

PMID:
20067632
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Synthetic lethal RNAi screening identifies sensitizing targets for gemcitabine therapy in pancreatic cancer.

Azorsa DO, Gonzales IM, Basu GD, Choudhary A, Arora S, Bisanz KM, Kiefer JA, Henderson MC, Trent JM, Von Hoff DD, Mousses S.

J Transl Med. 2009 Jun 11;7:43. doi: 10.1186/1479-5876-7-43.

PMID:
19519883
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk